Functional approach to a Class II patient with upper first molar impaction

Autor: Giacomo D′Orlandi, Lorenzo Raguzzi, Efisio Defraia, Felicita Pierleoni

Publikováno v: Indian Journal of Dental Research, Vol 25, Iss 5, Pp 662-666 (2014)

The lack of the left first molar maxillary and the left second molar maxillary, caused respectively by impaction and agenesis is a very rare case, which determines an important occlusal imbalance and asymmetrical mandible movement. A gnatologic and f

Externí odkaz: https://doaj.org/article/0f8445df51d44c95b6a7a18cbedfc54e

Management of patients with cancer during the COVID-19 pandemic: The Italian perspective on the second wave

Autor: Clementina Savastano, Francesco Grossi, Rosa Rita Silva, M. Schena, Angela Stefania Ribecco, Efisio Defraia, Fabrizio Artioli, Graziella Pinotti, Antonino Iaria, Monica Giordano, Teresa Gamucci, Daniele Bernardi, Alfredo Butera, Carlo Aschele, Riccardo Rossetti, Silvana Leo, Gianpiero Fasola, Alice Indini, Livio Blasi

Publikováno v: European Journal of Cancer

The novel Coronavirus Disease 2019 (COVID-19) pandemic has been an overwhelming challenge for worldwide health systems. Since the beginning of year 2020, COVID-19 has represented a potential harm for cancer patients and has often hindered oncology ca

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::978030b616bb18d3b1859c814a85fb74
https://pubmed.ncbi.nlm.nih.gov/33743478

Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial

Autor: Luca Boni, Carmelo Tibaldi, Claudio Dazzi, F. Zanelli, Ferdinando Riccardi, Editta Baldini, Nicoletta Zilembo, Rita Chiari, Francesca Ambrosio, Andrea Ardizzoni, Andrea Camerini, Gianni Michele Turolla, Francesco Grossi, Saverio Cinieri, Marcello Tiseo, Efisio Defraia, Vito D'Alessandro, Matteo Brighenti, Anna Rita Trolese

Publikováno v: Journal of Clinical Oncology. 35:1281-1287

Purpose Considering promising results in phase II studies, a randomized phase III trial was designed to assess the efficacy of adding bevacizumab to first-line cisplatin plus etoposide for treatment of extensive-disease (ED) small-cell lung cancer (S

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93ab92bcce61585d774ca44803023d78
https://doi.org/10.1200/jco.2016.69.4844

Three-dimensional evaluation of the maxillary effects of two orthopaedic protocols for the treatment of Class III malocclusion: A prospective study

Autor: Brittany Fischer, Cosimo Nardi, Lorenzo Franchi, Michele Nieri, Antonio Carlos de Oliveira Ruellas, James A. McNamara, Efisio Defraia, Veronica Giuntini, Caterina Masucci, Lucia H. S. Cevidanes

Publikováno v: Orthodonticscraniofacial research. 21(4)

Objectives To compare the three-dimensional maxillary dentoskeletal effects of a modified alternate rapid maxillary expansion and constriction facemask protocol (Alt-RAMEC/FM) with the traditional rapid maxillary expansion facemask protocol (RME/FM)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6af8a73b8eeb1206ea92b0556dd876fb
https://pubmed.ncbi.nlm.nih.gov/30253035

Impact of tissue type and content of neoplastic cells of samples on the quality of epidermal growth factor receptor mutation analysis among patients with lung adenocarcinoma

Autor: Francesca Capelli, Giuseppe Porcu, Antonio Pazzola, Efisio Defraia, Annamaria Carta, Maria Cristina Sini, Maria Colombino, Giovanni Maria Fadda, Panagiotis Paliogiannis, Giuseppe Palmieri, Antonio Cossu, Salvatore Ortu, Lorenzo Cordero, Giovanni Sotgiu, Grazia Palomba, Maria Ignazia Sotgiu, Federico Attene

Publikováno v: Molecular Medicine Reports
Molecular Medicine Reports in press (2014).
info:cnr-pdr/source/autori:Paliogiannis P, Attene F, Cossu A, Defraia E, Porcu G, Carta A, Sotgiu MI, Pazzola A, Cordero L, Capelli F, Fadda GM, Ortu S, Sotgiu G7, Palomba G, Sini MC, Palmieri G, Colombino M/titolo:Impact of tissue type and content of neoplastic cells in the specimen on the quality of epidermal growth factor receptor mutation analysis among patients with lung adenocarcinoma./doi:/rivista:Molecular Medicine Reports/anno:2014/pagina_da:/pagina_a:/intervallo_pagine:/volume:in press
Molecular Medicine Reports 12 (2015): 187. doi:10.3892/mmr.2015.3347
info:cnr-pdr/source/autori:Paliogiannis P, Attene F, Cossu A, Defraia E, Porcu G, Carta A, Sotgiu MI, Pazzola A, Cordero L, Capelli F, Fadda G, Ortu S, Sotgiu G, Palomba G, Sini M, Palmieri G*, Colombino M/titolo:Impact of tissue type and content of neoplastic cells in the specimen on the quality of epidermal growth factor receptor mutation analysis among patients with lung adenocarcinoma./doi:10.3892%2Fmmr.2015.3347/rivista:Molecular Medicine Reports/anno:2015/pagina_da:/pagina_a:187/intervallo_pagine:187/volume:12

Assessment of the epidermal growth factor receptor (EGFR) mutational status has become crucial in recent years in the molecular classification of patients with lung cancer. The impact of the type and quantity of malignant cells of the neoplastic spec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::caa08a8bb525fdd3b0352e900c543dee
https://doi.org/10.3892/mmr.2015.3347